BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33788166)

  • 21. Relationship Between Dexamethasone Suppression Test Cortisol Level >0.9 μg/dL and Depression and Quality of Life in Adrenal Incidentalomas: A Single Center Observational Case-Control Study.
    Güneş M; Güneş E; Kaya Mİ; Küçükelyas HD; Barut H; Öner S
    Endocr Pract; 2024 May; ():. PubMed ID: 38729569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterisation of the urinary steroid profile of patients with nonfunctioning adrenal incidentalomas: A matched controlled cross-sectional study.
    Araujo-Castro M; Casals G; Hanzu FA; Pascual-Corrales E; García Cano AM; Lanza VF; Luis Del Rey Mejías Á; Marchan M; Escobar-Morreale HF; Valderrabano P
    Clin Endocrinol (Oxf); 2023 Feb; 98(2):165-176. PubMed ID: 35973974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas.
    Araujo-Castro M; Parra Ramírez P; Robles Lázaro C; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
    Hormones (Athens); 2021 Dec; 20(4):735-744. PubMed ID: 34273083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonfunctioning adrenal incidentaloma affecting central blood pressure and arterial stiffness parameters.
    Akkan T; Altay M; Ünsal Y; Dağdeviren M; Beyan E
    Endocrine; 2017 Dec; 58(3):513-520. PubMed ID: 29043559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Could a nonfunctional adrenal incidentaloma be a risk factor for increased carotid intima-media thickness and 10-year cardiovascular mortality based on the SCORE algorithm? A study from a single centre in Poland.
    Szychlińska M; Rzeczkowska M; Matuszewski W; Bandurska-Stankiewicz E
    Endokrynol Pol; 2023; 74(6):. PubMed ID: 37994583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonfunctioning Adrenal Incidentalomas are not Clinically Silent: A Longitudinal Cohort Study.
    Kim JH; Kim MJ; Lee JH; Yoon JW; Shin CS
    Endocr Pract; 2020 Dec; 26(12):1406-1415. PubMed ID: 33471732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maximum adenoma diameter, regardless of uni- or bilaterality, is a risk factor for autonomous cortisol secretion in adrenal incidentalomas.
    Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
    J Endocrinol Invest; 2021 Nov; 44(11):2349-2357. PubMed ID: 33683661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible, probable, and certain hypercortisolism: A continuum in the risk of comorbidity.
    Araujo-Castro M; Pascual-Corrales E; Lamas C
    Ann Endocrinol (Paris); 2023 Apr; 84(2):272-284. PubMed ID: 36736771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of cortisol and adrenal androgen on bone mass in Asians with and without subclinical hypercortisolism.
    Ahn SH; Kim JH; Cho YY; Suh S; Kim BJ; Hong S; Lee SH; Koh JM; Song KH
    Osteoporos Int; 2019 May; 30(5):1059-1069. PubMed ID: 30719548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma Steroid Profiling in Patients With Adrenal Incidentaloma.
    Berke K; Constantinescu G; Masjkur J; Kimpel O; Dischinger U; Peitzsch M; Kwapiszewska A; Dobrowolski P; Nölting S; Reincke M; Beuschlein F; Bornstein SR; Prejbisz A; Lenders JWM; Fassnacht M; Eisenhofer G
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e1181-e1192. PubMed ID: 34665854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased Rates of Coronary Artery Calcium Score in Patients with Non - Functioning Adrenal Incidentaloma.
    Akkus O; Akkus G; Kaypakli O; Ozturk FK; Gurkan E; Bekler O; Sen F; Yalcin F
    Endocr Metab Immune Disord Drug Targets; 2021; 21(7):1319-1325. PubMed ID: 32914728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular events in patients with mild autonomous cortisol secretion: analysis with artificial neural networks.
    Morelli V; Palmieri S; Lania A; Tresoldi A; Corbetta S; Cairoli E; Eller-Vainicher C; Arosio M; Copetti M; Grossi E; Chiodini I
    Eur J Endocrinol; 2017 Jul; 177(1):73-83. PubMed ID: 28468767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatosteatosis in patients with adrenal incidentaloma: A risk factor for impaired glucose metabolism.
    Candemir B; Kisip K; Akın Ş; Tuba Sanal H; Taşar M; Altunkaynak B; Ersöz Gülçelik N
    Diabetes Res Clin Pract; 2024 Feb; 208():111099. PubMed ID: 38246510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk.
    Di Dalmazi G; Fanelli F; Zavatta G; Ricci Bitti S; Mezzullo M; Repaci A; Pelusi C; Gambineri A; Altieri P; Mosconi C; Balacchi C; Golfieri R; Cosentino ER; Borghi C; Vicennati V; Pasquali R; Pagotto U
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5519-5528. PubMed ID: 31381072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adipocytokines in Non-functional Adrenal Incidentalomas and Relation with Insulin Resistance Parameters.
    Akkus G; Evran M; Sert M; Tetiker T
    Endocr Metab Immune Disord Drug Targets; 2019; 19(3):326-332. PubMed ID: 30306882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic testing of autonomous cortisol secretion in adrenal incidentalomas.
    Ueland GÅ; Grinde T; Methlie P; Kelp O; Løvås K; Husebye ES
    Endocr Connect; 2020 Oct; 9(10):963-970. PubMed ID: 33032259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center.
    Patrova J; Kjellman M; Wahrenberg H; Falhammar H
    Endocrine; 2017 Nov; 58(2):267-275. PubMed ID: 28887710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuation Value in Adrenal Incidentalomas: A Longitudinal Study.
    Ceccato F; Tizianel I; Voltan G; Maggetto G; Merante Boschin I; Quaia E; Crimì F; Scaroni C
    Front Endocrinol (Lausanne); 2021; 12():794197. PubMed ID: 34925247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of DHEAS as a Screening Test for Autonomous Cortisol Secretion in Adrenal Incidentalomas: A Prospective Study.
    Liu MS; Lou Y; Chen H; Wang YJ; Zhang ZW; Li P; Zhu DL
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e1789-e1796. PubMed ID: 35137142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depression: another cortisol-related comorbidity in patients with adrenal incidentalomas and (possible) autonomous cortisol secretion.
    Šojat AS; Dunjić-Kostić B; Marina LV; Ivović M; Radonjić NV; Kendereški A; Ćirković A; Tančić-Gajić M; Arizanović Z; Mihajlović S; Vujović S
    J Endocrinol Invest; 2021 Sep; 44(9):1935-1945. PubMed ID: 33528757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.